Defective adenoviruses and corresponding complementation lines

Details Defective adenoviruses and corresponding complementation lines Defective adenoviruses and corresponding complementation lines

2006-02-28

2006-02-28

Priebe, Scott D. (Department: 1632)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

C435S091100, C435S320100, C435S325000, C435S366000, C435S455000, C435S456000, C424S093200

Reexamination Certificate

active

07005277

ABSTRACT:
Novel defective adenoviruses for the transfer and expression of an exogenous nucleotide sequence in a host cell or organism. The invention also relates to novel complementation lines and to the process for the preparation of these novel defective adenoviruses and their use in therapy and to a pharmaceutical composition containing same.

REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5700470 (1997-12-01), Saito et al.
patent: 5981275 (1999-11-01), Armentano et al.
patent: 5994106 (1999-11-01), Kovesdi et al.
patent: 6099831 (2000-08-01), Perricaudet et al.
patent: WO 93/06223 (1993-04-01), None
patent: WO 93/19191 (1993-09-01), None
patent: WO 94/12649 (1994-06-01), None
patent: WO 94/28152 (1994-12-01), None
Krougliak et al.,Human Gene Therapy, 6:1575-1586 (1995).
Yeh et al.,Journal of Virology, 70(1):559-565 (1996).
Wang et al.,Gene Therapy, 2:775-783 (1995).
Fallaux et al.,Human Gene Therapy, 9:1909-1917 (1998).
Fallaux et al.,Human Gene Therapy, 7:215-222 (1996).
Senear et al.,Molecular and Cellular Biology, 6(4):1253-1260 (1986).
Bernards et al.,Virology, 120:422-432 (1982).
Roberts et al.,Journal of Virology, 56(2):404-413 (1985).
Vaessen et al.,The EMBO Journal, 5(2):335-341, (1986).
Louis et al.,Virology, 233:423-429 (1997).
Chrobocek et al.,Virology, 186:280-285 (1992).
Berkner,Current Topics in Microbiology and Immunology, 158:39-66 (1992).
Grable et al.,Journal of Virology, 64(5):2047-2056, (May 1990).
Armentano et al.,Human Gene Therapy, 6:1343-1353 (1995).
Klessig et al.,Molecular and Cellular Biology, 4(7):1354-1362 (1984).
Englehardt et al.,Proc. Natl. Acad. Sci., 91:6196-6200 (1994).
Gao et al.,Journal of Virology, 70(12):8934-8943 (1996).
Mastrangeli et al.,The Journal of Clinical Investigation, Inc., 91:225-234 (1993).
Rosenfeld et al.,Science, 252:431-434 (1991).
Randrianarison-Jewtoukoff et al.,Biologicals, 23:145-157 (1995).
Trapnell et al.,Current Opinion in Biotechnology, 5:617-625 (1994).
Lusky et al.,Journal of Virology, 72(3):2022-2032 (1998).
Wang et al.,Gene Therapy, 4:393-400 (1997).
LaFont et al.,Lancet, 346:1442-1443 (1995).
Marshall,Science, 269:1050-1055 (1995).
Miller et al.,FASEBJ, 9:190-199 (1995).
Culver et al.,TIG, 10(5):174-178 (1994).
Hodgson,Exp. Opin. Ther. Pat., 5(5):459-468 (1995).
Berkner et al.,Biotechniques, 6(7):616-628 (1988).
Weinberg et al.,Proc. Nat. Acad. Sci., 80:5383-5386 (1993).
Bajocchi et al.,Nature Genetics, 3:229-234 (1993).
James et al.,Antiviral Chem. Chemo., 2(4):191-214 (1991).
Babiss,Journal of Virology, 62(6):2709-2717 (1989).
Statford-Perricaudet et al.,Human Gene Transfer, 219:51-61 (1991).
Rosenfeld et al.,Cell, 68(1):143-155 (1992).
Imler et al.,Gene Therapy, 3:75-84 (1996).
Bellon et al.,Human Gene Therapy, 8:15-25 (1997).
Ketner, et al.,Nucleic Acids Research, 17(8):3037-3048 (1989).

Affiliated with

Also associated with

Rating

Defective adenoviruses and corresponding complementation lines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Defective adenoviruses and corresponding complementation lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Defective adenoviruses and corresponding complementation lines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3684296